Analysis

J&J's Talc Trial Deal Shows Power Of FDA's Asbestos Finding

Law360 (January 7, 2020, 9:28 PM EST) -- A rare midtrial settlement Johnson & Johnson reached this week with a woman who said its baby powder caused her cancer could signal an increased trial risk the company faces from the FDA's recent finding of asbestos in its talc, which took center stage in the case.

As J&J has taken dozens of talc cases to trial in recent years, it has consistently told juries that trustworthy sources like federal regulators have never found the carcinogen in its talc, only plaintiffs' paid experts. Juries appeared to be responding to these arguments, delivering wins for J&J in the last four talc trials...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!